In vitro activity of bedaquiline against slow-growing nontuberculous mycobacteria.

Last updated on 20-6-2019 by Vanessa Mathys

Peer reviewed scientific article

Engels

SCIENSANO

Samenvatting:

Bedaquiline (BDQ) is a recently approved antibiotic for the treatment of multidrug-resistant tuberculosis, but its potential against slow-growing mycobacteria (SGM) is still unknown. The objective of this study was to determine the in vitro activity of BDQ on SGM by assessing their MIC and minimal bactericidal concentration (MBC). The MIC of BDQ against 17 clinical isolates including Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium chimaera, Mycobacterium kansasii and Mycobacterium simiae species was determined by the resazurin microtitre assay and the MBC by the c.f.u. dete…

Associated health topics:

QR code

QR code for this page URL